RBC Capital Upgrades Neurocrine Bio. (NBIX) to Outperform
Tweet Send to a Friend
(Updated - April 14, 2025 6:23 AM EDT)
RBC Capital analyst Brian Abrahams upgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams upgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
